Drug Repurposing for the Treatment of Acute Myeloid Leukemia

Drug Repurposing for the Treatment of Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a heterogeneous disease characterized by the accumulation of immature myeloid progenitor cells in the bone marrow, compromising of normal blood cell production and ultimately resulting in bone marrow failure. With a 20% overall survival rate at 5 years and 50% in the...

Full description

Bibliographic Details
Main Authors:	Vibeke Andresen, Bjørn T. Gjertsen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-11-01
Series:	Frontiers in Medicine
Subjects:	drug repurposing drug repositioning biomarkers cancer acute myeloid leukemia therapy development
Online Access:	http://journal.frontiersin.org/article/10.3389/fmed.2017.00211/full

Similar Items

Repurposing Drugs for Acute Myeloid Leukemia: A Worthy Cause or a Futile Pursuit?
by: Anna V. Wojcicki, et al.
Published: (2020-02-01)

Has Drug Repurposing Fulfilled its Promise in Acute Myeloid Leukaemia?
by: Debora Valli, et al.
Published: (2020-06-01)

Prospects for repurposing CNS drugs for cancer treatment
by: Mohamed Abdelaleem, et al.
Published: (2019-04-01)

Colony Stimulating Factor 1 Receptor in Acute Myeloid Leukemia
by: Kristine Yttersian Sletta, et al.
Published: (2021-03-01)

Editorial: Drug Repurposing
by: Pan Pantziarka, et al.
Published: (2019-07-01)

“Hard” Drug Repurposing for Precision Oncology: The Missing Link?
by: Pan Pantziarka, et al.
Published: (2018-06-01)

Challenges for Drug Repurposing in the COVID-19 Pandemic Era
by: Janet Sultana, et al.
Published: (2020-11-01)

Immunomodulatory Drugs in Acute Myeloid Leukemia Treatment
by: Antonio Piccolomo, et al.
Published: (2020-09-01)

Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling
by: Daniele Mercatelli, et al.
Published: (2020-05-01)

Repurposing Drugs to Treat Heart and Brain Illness
by: Maranda S. Cantrell, et al.
Published: (2021-06-01)

Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs
by: Daniele Parisi, et al.
Published: (2020-01-01)

Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates
by: Laura De Lellis, et al.
Published: (2021-08-01)

Overcoming Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: Repurposed Drugs Can Improve the Protocol
by: Miguel Olivas-Aguirre, et al.
Published: (2021-03-01)

Repurposing drugs for the treatment and control of helminth infections
by: Gordana Panic, et al.
Published: (2014-12-01)

Recent drug approvals for acute myeloid leukemia
by: Catherine Lai, et al.
Published: (2019-09-01)

SPIDR: small-molecule peptide-influenced drug repurposing
by: Matthew D. King, et al.
Published: (2018-04-01)

Drug Repurposing for Targeting Acute Leukemia With KMT2A (MLL)—Gene Rearrangements
by: Alexia Tsakaneli, et al.
Published: (2021-09-01)

Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy
by: Andrés Pizzorno, et al.
Published: (2019-03-01)

Doxazosin, a Classic Alpha 1-Adrenoceptor Antagonist, Overcomes Osimertinib Resistance in Cancer Cells via the Upregulation of Autophagy as Drug Repurposing
by: Shuhei Suzuki, et al.
Published: (2020-08-01)

Filling the gap in CNS drug development: evaluation of the role of drug repurposing
by: A. Caban, et al.
Published: (2017-01-01)

Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent
by: Debbie-Ann Shirley, et al.
Published: (2021-03-01)

Mechanisms of drug resistance in acute myeloid leukemia
by: Zhang J, et al.
Published: (2019-03-01)

Suppressing Hedgehog signaling reverses drug resistance of refractory acute myeloid leukemia
by: Huang K, et al.
Published: (2019-09-01)

Advances in the drug therapies of acute myeloid leukemia (except acute promyelocytic leukemia)
by: Lin M, et al.
Published: (2018-04-01)

A drug repurposing study based on clinical big data for the treatment of interstitial lung disease
by: SONI, SISWANTO
Published: (2020)

New and Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia (AML)
by: Jing Chen, et al.
Published: (2020-02-01)

Drug repurposing for the treatment of glioblastoma multiforme
by: Claudia Abbruzzese, et al.
Published: (2017-11-01)

Azacitidine and lenalidomide as an alternative treatment for refractory acute myeloid leukemia: a case report
by: Juliana Todaro, et al.

Treatment of Acute Myeloid Leukemia in the Era of Genomics—Achievements and Persisting Challenges
by: Steven D. Green, et al.
Published: (2020-05-01)

The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases – recommendations of the IRDiRC Data Mining and Repurposing Task Force
by: Noel T Southall, et al.
Published: (2019-10-01)

Repurposing drugs: Lessons from rheumatology in the COVID-19 pandemic
by: Manesh Manoj, et al.
Published: (2021-01-01)

Multiplex Screening for Interacting Compounds in Paediatric Acute Myeloid Leukaemia
by: Lauren V. Cairns, et al.
Published: (2021-09-01)

Mechanism of sorafenib resistance in FLT3-ITD⁺ acute myeloid leukemia
by: Man, Cheuk-him, et al.
Published: (2014)

Drug responsiveness of leukemic cells detected in vitro at diagnosis correlates with therapy response and survival in patients with acute myeloid leukemia
by: Maria A. Kolesnikova, et al.
Published: (2021-08-01)

Molecular Targeting and Rational Chemotherapy in Acute Myeloid Leukemia
by: Pourrajab F, et al.
Published: (2020-05-01)

Drug Repurposing on G Protein-Coupled Receptors Using a Computational Profiling Approach
by: Alessandra de Felice, et al.
Published: (2021-05-01)

Drug Repurposing for the Management of Depression: Where Do We Stand Currently?
by: Hosna Mohammad Sadeghi, et al.
Published: (2021-07-01)

Current Therapeutic Results and Treatment Options for Older Patients with Relapsed Acute Myeloid Leukemia
by: Felicetto Ferrara, et al.
Published: (2019-02-01)

Drug Repurposing in Medical Mycology: Identification of Compounds as Potential Antifungals to Overcome the Emergence of Multidrug-Resistant Fungi
by: Lucie Peyclit, et al.
Published: (2021-05-01)

A data-driven methodology towards evaluating the potential of drug repurposing hypotheses
by: Lucía Prieto Santamaría, et al.
Published: (2021-01-01)